B. Riley Securities Initiates Coverage On Centessa Pharmaceuticals with Buy Rating, Announces Price Target of $33
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has initiated coverage on Centessa Pharmaceuticals with a Buy rating and set a price target of $33.
September 19, 2024 | 11:25 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B. Riley Securities has initiated coverage on Centessa Pharmaceuticals with a Buy rating and a price target of $33, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $33 by B. Riley Securities suggests a positive sentiment towards Centessa Pharmaceuticals. This is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100